| Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Dec'15 | Sep'15 | Jun'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||||
Net income (loss) | ||||||||||||
3,028 | 167 | -242 | -1,185 | -1,801 | -1,871 | -1,686 | -1,573 | -1,346 | -1,255 | 0 | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||||||
Interest on cash and cash equivalents held in Trust Account | ||||||||||||
1,810 | 1,534 | 1,232 | 895 | 641 | 405 | 308 | 269 | 166 | 79 | 0 | 0 | 0 |
Interest on convertible note to Sponsor | ||||||||||||
33 | 25 | 18 | 11 | 5 | 2 | 0 | 0 | 0 | 0 | - | - | - |
Provision for uncollectible other receivables | ||||||||||||
0 | 0 | 278 | 556 | 556 | 556 | 278 | 0 | 0 | 0 | - | - | - |
Changes in operating assets and liabilities: | ||||||||||||
Prepaid expenses | ||||||||||||
-15 | -61 | -10 | -20 | 0 | -31 | -78 | -82 | 44 | 97 | 0 | 0 | 0 |
Other receivables | ||||||||||||
0 | 0 | -1 | -165 | -268 | 486 | 488 | 721 | 824 | 69 | 0 | 0 | 0 |
Accounts payable and accrued expenses | ||||||||||||
445 | 200 | -4 | 290 | 694 | 1,383 | 1,442 | 1,081 | 986 | 217 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||||||
-864 | -727 | -817 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Cash flows from investing activities: | ||||||||||||
Net cash used in operating activities | ||||||||||||
- | - | - | - | - | - | - | - | 0 | -1,261 | - | 0 | 0 |
Cash released from Trust Account for redemption of common stock | ||||||||||||
-8,401 | -71 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Interest income released from Trust Account for franchise taxes | ||||||||||||
209 | 201 | 226 | 216 | 322 | 299 | 216 | 190 | 48 | 0 | 0 | 0 | 0 |
Contributions into Trust Account | ||||||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - | - | - | - |
Net cash provided by investing activities | ||||||||||||
55,581 | 48,820 | 50,126 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Cash flows from financing activities: | ||||||||||||
Proceeds of convertible note received from Sponsor | ||||||||||||
-25 | -150 | 0 | 460 | 310 | 235 | 0 | 0 | 0 | 0 | - | - | - |
Redemption of common stock | ||||||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - | - | - | - |
Due to affiliate | ||||||||||||
448 | 430 | 352 | 298 | 273 | 256 | 205 | 147 | 78 | 23 | 0 | 0 | 0 |
Net cash provided by investing activities | ||||||||||||
- | - | - | - | - | - | - | - | 0 | -200,000 | - | 0 | 0 |
Proceeds from issuance of common stock to initial stockholder | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Proceeds from promissory note | ||||||||||||
0 | 0 | - | - | 0 | 0 | - | - | - | - | 0 | 0 | 0 |
Net cash (used in) provided by financing activities | ||||||||||||
-54,721 | -48,111 | -49,319 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Payment of deferred offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | ||||||||||||
- | - | - | - | - | - | - | - | 0 | 201,272 | - | 0 | 0 |
Decrease in cash | ||||||||||||
-4 | -18 | -10 | -48 | 2 | 15 | -248 | -1,046 | -70 | 11 | 0 | 0 | 0 |
Supplemental disclosure of noncash financing activities: | ||||||||||||
Offering costs included in accrued offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 |
Payment of offering costs through advance from related party | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Change in value of common stock subject to possible redemption | ||||||||||||
-3,513 | 167 | -242 | -1,185 | -1,059 | -1,871 | -1,686 | 0 | 0 | 0 | - | - | - |